Skip to content
My WebMD Sign In, Sign Up
A LETTER FROM PURDUE REGARDING THE NEW OXYCONTIN 80MG
avatar
rjbeck77 posted:
This is a letter from Purdue Pharma.

October 4, 2010

Dear Healthcare Professional:
On April 5, 2010, the U.S. Food and Drug Administration (FDA) approved Purdue Pharma
New Drug Application for a reformulation of 80mg OxyContin
® (oxycodone hydrochloride
controlled-release) Tablets. Purdue elected to reformulate OxyContin to be bioequivalent to
the original formulation and in an effort to make the tablet more difficult to manipulate for
the purpose of intentional misuse and abuse, however, there is no evidence that the
reformulation of OxyContin is less subject to misuse, abuse, diversion, overdose, or addiction.
Since introducing reformulated OxyContin to the market on August 9, 2010, Purdue has
received reports that some patients are encountering diffi culties with swallowing
the reformulated tablet. Purdue encourages you to counsel your patients on
appropriately taking this medication and to remind them that:
"022 OxyContin Tablets should be taken one tablet at a time, with enough water to
ensure complete swallowing immediately after placing in the mouth
"022 Multiple tablets should not be swallowed together
"022 Tablets should not be dampened, soaked, licked, or otherwise wet prior to
placing them in the mouth for immediate swallowing

Regards RB
Reply


Featuring Experts

David N. Maine, MD is the director of the Center for Interventional Pain Medicine at Mercy Medical Center in Baltimore. Maine graduated with a degree ...More

Health Insurance in Your State

Learn about plans, benefits, and costs in your state's Marketplace.

From WebMD

Helpful Tips

Severe Chronic Pain Lowers Life Expectancy
Previous research has demonstrated a clearly negative influence of chronic pain on health. Now, a new study portrays a profound link ... More
Was this Helpful?
166 of 198 found this helpful

Report Problems to the
Food and Drug Administration

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.